In this episode, we chat with our friend Bari Talente, Executive VP, Advocacy, for the National MS Society. Bari explains specific legislation, HR3 - Lower Drug Costs Now Act of 2019, which addresses the high costs of MS disease modifying therapies. She expands on the importance of these difficult conversations in order to ensure individuals living with MS have access to affordable medications. She shares her experience during a recent Congressional Hearing where she testified on behalf of the MS community and how you are encouraged to get involved.  Yes, we can all make a difference with respect to high drug costs. Stay up-to-date on HR3, as well as advocacy policies, by signing up for the MS Activist Network and following on Twitter (@MSactivist). See if your Legislator supports this new legislation at Congress.gov and sign up to get alerts as this important legislation moves forward.